WHO ICTRP trial
Can magnesium enhance blood coagulation amongst patients with alcohol induced…
EUCTR2012-005454-35-FI · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2012-005454-35-FI |
|---|---|
| Public title | Can magnesium enhance blood coagulation amongst patients with alcohol induced liver cirrhosis? |
| Scientific title | Can magnesium enhance blood coagulation amongst patients with alcohol induced liver cirrhosis? - MG001 |
| Primary sponsor | Hanna Pitkänen |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Finland |
| Conditions | Liver transplant candidates with alcohol induced liver cirrhosis and hypomagnesemia (P-Mg under 0,71 or magnesium substitution at least 750 mg/day) MedDRA version: 14.1 Level: LLT Classification code 10024667 Term: Liver cirrhosis System… |
| Interventions | Trade Name: Addex-Magnesium sulfate 246 mg/ml infusion concentrate for solution Product Name: Addex-Magnesium sulfate 246 mg/ml infusion concentrate for solution Pharmaceutical Form: Concentrate for solution for infusion Other descriptive… |
| Registration date | Feb 19, 2013 |
| Secondary IDs | MG001 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: